NF-κB in colorectal cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Colorectal cancer (CRC) is a major global health burden, causing significant mortality.
• CRC development involves genetic mutations, epigenetic alterations, and pathway dysregulation, notably the Wnt pathway.
• Nuclear factor kappa B (NF-κB) is a critical transcription factor implicated in CRC initiation and progression.

Purpose of the Study:

• To elucidate the role of NF-κB signaling in colorectal cancer.
• To explore NF-κB's involvement in the tumor microenvironment.
• To identify NF-κB as a potential therapeutic target for CRC.

Main Methods:

• Review of experimental data on NF-κB signaling in CRC.
• Analysis of NF-κB's role in tumor cells and the tumor microenvironment.
• Investigation of therapeutic strategies targeting the NF-κB pathway.

Main Results:

• NF-κB is essential for CRC initiation and propagation.
• NF-κB signaling is active in both tumor cells and the surrounding microenvironment.
• NF-κB promotes inflammation, proliferation, angiogenesis, invasion, and metastasis in CRC.

Conclusions:

• NF-κB and its associated network are crucial drivers of colorectal cancer.
• Targeting the NF-κB pathway offers a promising therapeutic strategy for CRC.
• NF-κB-targeted therapies may lead to more effective treatments with fewer side effects.